患者,女,44岁,因"双眼红疼、视力下降,20余天"来院就诊,以"角膜溃疡(右眼)干眼症(双眼)"收入院.既往干眼症病史10余年,2002年曾行右眼颌下腺移植术,术后眼部症状略缓解;2008年行左眼颌下腺移植术,效果欠佳.双眼干涩不适频繁发作,视力逐渐下降,自备抗生素滴眼液应用,症状可缓解,本次发作后,自购药品点眼效果不佳.入院查体:视力右眼:手动/眼前、左眼:指数/30cm,指测眼压双眼正常,双
Objective: Long non-coding RNAs (lncRNAs) have recently emerged as a major class of regulatory molecules involved in a broad range of biological processes and complex diseases.In this study, we explor
Objective: Our aim was to investigate how radiofrequency ablation (RFA) and transcatheter arterial chemoemblization (TACE) affected liver function in patients with hepatocellular carcinoma (HCC) and a
Objective: Licochalcone A(LCA) is a flavonoid extracted from licorice root that has anti-parasitic, anti-bacterial, and anti-tumor properties.To assess the potential antitumor effects of LCA alone or
Objective: We compared clinical characteristics and prognoses of Uyghur patients with hepatocellular carcinoma (HCC) in Xinjiang, China.Method: We retrospectively analyzed clinical data of 301 Uyghur
Objective: The aim of this study was to evaluate the efficacy and safety of Continuous 5-fluorouracil infusion in malignant bowel obstruction due to peritoneal dissemination from gastric cancer.Method
Objective: Advanced hepatocellular carcinoma (HCC) is a leading cause of cancer death, particularly in Asia where ～80％ of HCC incidences occur.Although sorafenib is the recommended treatment, it is no
目的:观察早期乳腺癌保乳术后全乳腺大分割照射同步瘤加量的近期疗效、毒副反应,探讨其治疗可行性.方法:纳入吉林省肿瘤医院2011年2月～2012年2月收治的Ⅰ、Ⅱ期乳腺癌保乳术后患者54例,予全乳腺大分割照射同步瘤床加量,具体放疗方式为:采用6MV-X的调强放疗,全乳腺照射40.5Gy/15次,2.7Gy/次,同步瘤床加量至48 Gy/15次,3.2Gy/次.
Objective: No standard treatment options are available for HCC progressing despite SOR treatment.The oral multikinase inhibitor REG showed acceptable tolerability and antitumor activity in patients wi
Objective: As a specific inhibitor of thymidylate synthase (TS), raltitrexed has been shown to prolong survival for patients with advanced gastric cancer in our clinical practice.However, the possible